Sign in / Join Now
ETFs & Funds
Idera Pharmaceuticals (IDRA) Positive Top-Line Data From Psoriasis Trial, Horizon Pharma... $
Add a reply...
Latest StockTalks »
people get IDRA breaking news and analysis by email alert.
Get email alerts on IDRA »
Idera Pharmaceuticals, Inc.
Get latest price
From other sites
Idera Pharmaceuticals Presents New Third Generation Antisense (3GA) Data At The 12th Annual Meeting Of The Oligonucleotide Therapeutics Society
at TheStreet (Tue, 7:30AM)
Idera Pharmaceuticals Reports Promising Data From Ongoing Phase 1 Dose Escalation In Clinical Trial Of Intra-tumoral IMO-2125 In Combination With Ipilimumab In Patients With PD-1 Refractory Metastatic Melanoma
at TheStreet (Mon, 7:00AM)
Idera Pharmaceuticals in Focus: Stock Adds 8.8% in Session
at Zacks.com (Sep 20, 2016)
Idera Pharmaceuticals Presents The Novel Mechanism Of Action Of Its Third Generation Antisense Technology
at TheStreet (Aug 24, 2016)
Idera To Present At The 2016 Wedbush PacGrow Healthcare Conference
at TheStreet (Aug 12, 2016)